Insights from CYLCOMED’s 5th Consortium Meeting

On February 18-19, the CYLCOMED project held its 5th consortium meeting, hosted by partner MediaClinics Italia in Trento. MediaClinics Italia is an expert medical device manufacturer and an innovative SME.

Over the two days, partners shared updates on their progress, including:

  • Technical advancements: Details on integration and validation with real-world applications, including pilot programs.
  • Cybersecurity progress: XLAB, Eviden, and Martel provided updates on the status, timeline, achievements, and next steps for the cybersecurity toolbox.
  • Risk management: INOV presented an overview of risk management within the connected medical devices (CMDs) field, including risk-benefit schemes and frameworks.
  • Legal guidance: KU Leuven discussed their involvement in dissemination activities and progress on legal guidance for the consortium.
  • Standardization: A comprehensive report on standardization activities was also presented.
  • Awareness raising and communication: An outlook of approaching conferences and partnership with sibling projects
CYLCOMED's 5th Consortium Meeting

Looking ahead

Now in its 28th month, CYLCOMED is approaching its final semester. Live meetings like this, where both technical and medical partners can share their unique perspectives, are essential for effective discussion of challenges and establishing a clear path forward.

Together, our consortium is working to boost the cybersecurity of CMDs for the benefit of hospitals and patients!

Our next consortium meeting will take place in October – Stay tuned for more!

Similar Posts

  • Meet the CYLCOMED partner: Ospedale Pediatrico Bambino Gesú

    Ospedale Pediatrico Bambino Gesú (Bambino Gesù Pediatric Hospital) is a 607-bed tertiary care academic hospital located in the Lazio Region of Italy. Recognized as a Scientific Institute for Research, Hospitalization, and Health Care (IRCCS), it serves as Italy’s leading pediatric hospital, delivering advanced healthcare services for children alongside robust basic, clinical, and translational research programs….

  • CYLCOMED Project Concludes: Key Highlights

    After three years of pioneering research, the CYLCOMED project is drawing to a close, leaving a significant mark on cybersecurity for connected medical devices (CMDs) across European healthcare systems. Launched in December 2022 as part of Horizon Europe’s Research and Innovation Action (RIA), the initiative has developed innovative solutions to protect critical medical technologies without…

  • CYLCOMED’s Journey Nears Completion with Final Meeting in Ljubljana

    In the captivating city of Ljubljana, the CYLCOMED consortium convened for its 6th and final plenary meeting, marking a significant moment as the project enters its concluding phase. Hosted by partner XLAB, the two-day gathering brought together all core partners for a pivotal exchange of progress, reflections, and final steps toward the upcoming project review….

  • Meet the CYLCOMED partner: INOV

    INOV – Instituto de Engenharia de Sistemas e Computadores Inovação, is one of the largest Portuguese technological infrastructures in the field of Information and Communication Technologies (ICT) and Electronics. INOV dates back to 2001, after it proceeded with the strategic restructuring of INESC – Instituto de Engenharia de Sistemas e Computadores back to 1998. Today, it is a private…

  • Meet the CYLCOMED partner: Charitè

    Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe. Here, physicians and researchers work, heal, and teach at the highest international level. More than half of Germany’s Nobel Prize winners in Medicine and Physiology have come from Charité, including Emil von Behring, Robert Koch, and Paul Ehrlich. The university hospital is…

  • Meet the CYLCOMED partner: XLAB

    XLAB is a global SME specializing in IT solutions, with a strong focus on hybrid infrastructure management and automation, cybersecurity and privacy, IoT, and data analytics. XLAB participated in over 80 research projects (more than 50 European and 30 national), and has a proven track record of translating research outcomes into successful products. One notable…